会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Trivalent silver water treatment compositions
    • 三价银水处理组合物
    • US5223149A
    • 1993-06-29
    • US884712
    • 1992-05-18
    • Marvin S. Antelman
    • Marvin S. Antelman
    • C02F1/50
    • C02F1/505C02F2103/42Y10S422/905
    • A method for controlling the growth of bacteria and algae in utilitarian bodies of water such as industrial cooling towers, swimming pools and hot tubs is described. The method comprises adding to the water novel trivalent silver compounds. Said compounds are light stable and can be supplied as liquid concentrates which will not precipitate any silver whatsoever from saline waters nor will the concentrates stain skin or discolor surfaces. Said compounds meet the rigid EPA standards of killing 100% of select coliforms within ten minutes and are efficacious at concentrations as low as 1-2 PPM.
    • 描述了一种用于控制诸如工业冷却塔,游泳池和热水浴缸的水的功利主义体内的细菌和藻类生长的方法。 该方法包括向水中加入新型三价银化合物。 所述化合物是光稳定的,可作为液体浓缩物供应,其不会从盐水中沉淀出任何银,也不会使浓缩物污染皮肤或变色表面。 所述化合物满足严格的EPA标准,在十分钟内杀死100%的选择大肠杆菌,并且在低至1-2PPM的浓度下是有效的。
    • 4. 发明授权
    • Method of curing AIDS with tetrasilver tetroxide molecular crystal
devices
    • 用四氧化四铁分子晶体装置治疗艾滋病的方法
    • US5676977A
    • 1997-10-14
    • US658955
    • 1996-05-31
    • Marvin S. Antelman
    • Marvin S. Antelman
    • A61K33/38
    • A61K33/38
    • The diamagnetic semiconducting molecular crystal tetrasilver tetroxide (Ag.sub.4 O.sub.4) is utilized for destroying the AIDS virus, destroying AIDS synergistic pathogens and immunity suppressing moieties (ISM) in humans. A single intravenous injection of the devices is all that is required for efficacy at levels of about 40 PPM of human blood. The device molecular crystal contains two mono and two trivalent silver ions capable of "firing" electrons capable of electrocuting the AIDS virus, pathogens and ISM. When administered into the bloodstream, the device electrons will be triggered by pathogens, a proliferating virus and ISM, and when fired will simultaneously trigger a redox chelation mechanism resulting in divalent silver moieties which chelate and bind active sites of the entities destroying them. The devices are completely non-toxic. However, they put stress on the liver causing hepatomegaly, but there is no loss of liver function.
    • 抗氧化半导体分子晶体四氧化四砷(Ag4O4)用于破坏艾滋病病毒,破坏艾滋病协同病原体和人体免疫抑制部分(ISM)。 单次静脉注射的装置全部是在约40PPM人血液中的功效所需要的。 器件分子晶体含有能够“烧制”能够电切艾滋病病毒,病原体和ISM的电子的两个一价和两价三价银离子。 当被施用到血液中时,器官电子将被病原体,增殖病毒和ISM引发,并且当被引发时将同时触发氧化还原螯合机制,导致二价银部分螯合并结合破坏它们的实体的活性位点。 设备完全无毒。 但是,他们强调肝脏引起肝肿大,但肝功能没有损失。
    • 6. 发明授权
    • Multivalent electron active compositions and methods of making and using same
    • 多价电子活性组合物及其制备和使用方法
    • US06645531B1
    • 2003-11-11
    • US09692126
    • 2000-10-20
    • Marvin S. Antelman
    • Marvin S. Antelman
    • A61K3334
    • A61K8/0208A61K8/19A61K9/0014A61K9/06A61K33/24A61K33/245A61K33/26A61K33/32A61K33/34A61K33/38A61K47/02A61Q1/12A61Q19/00C01G3/02Y02A50/481
    • The present invention is directed to pharmaceutical compositions that include a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has at least two polyvalent cations, at least one of which has a first valence state and at least one of which has a second, different valence state. Preferred compounds include Bi(III,V) oxide, Co(II,III) oxide, Cu(I,III) oxide, Fe(II,III) oxide, Mn(II,III) oxide, and Pr(III,IV) oxide, and optionally Ag(I,III) oxide. These compounds may be in a crystalline state having metallic cations of two different valences, or electronic states, in the inorganic crystal. In addition, the invention relates to methods for prevention, management, or treatment of a condition using these compounds or pharmaceutical compositions including the same.
    • 本发明涉及包含治疗有效量的至少一种电子活性化合物或其药学上可接受的衍生物的药物组合物,其具有至少两种多价阳离子,其中至少一种具有第一价态和至少一种 其中一个具有第二个不同的价态。 优选的化合物包括氧化物Bi(III),氧化物(II),氧化物(I),氧化物(III),氧化物(II),氧化物(III)),氧化物(II) 氧化物和任选的Ag(I,III)氧化物。 这些化合物可以是在无机晶体中具有两种不同价态的金属阳离子或电子态的结晶状态。 此外,本发明涉及使用这些化合物或包含其的药物组合物的病症的预防,治疗或治疗方法。
    • 7. 发明授权
    • Molecular crystal device for pharmaceuticals
    • 药用分子晶体装置
    • US5336499A
    • 1994-08-09
    • US971933
    • 1992-11-05
    • Marvin S. Antelman
    • Marvin S. Antelman
    • A01N59/16A61K8/19A61K9/00A61K33/38A61K47/02A61Q17/00A61K7/00
    • A61K9/0014A01N59/16A61K33/38A61K47/02A61K8/19A61K9/0019A61Q17/005A61K2800/524
    • A novel molecular scale device is described which is bactericidal, fungicidal, viricidal and algicidal. The anti-pathogenic properties of the device are attributed to electron activity indigenous to diamagnetic semiconducting crystals of tetrasilver tetroxide (Ag.sub.4 O.sub.4) which contains two monovalent and two trivalent silver ions in each molecular crystal. When the crystals are activated with an oxidizing agent, they release electrons equivalent to 6.4.times.10.sup.-19 watts per molecule which in effect electrocute pathogens. A multitude of these devices are effective at such low concentrations as 0.3 PPM used as preservatives in a variety of formulations ranging from cosmetics to pharmaceuticals. Indeed, they are intended as active ingredients for pharmaceuticals formulated to destroy such pathogens as Staphylococcus aureus, and epidermidis, the latter of which it completely destroys in a nutrient broth culture of about 1 million organisms at 0.6 PPM, or Candida albercans, the vaginal yeast infection at 2.5 PPM, and the AIDS virus at 18 PPM.
    • 描述了一种新颖的分子标尺装置,其具有杀菌,杀真菌,杀病毒和杀藻剂。 该装置的抗病原性质归因于在四分子四氧化物(Ag4O4)中含有两个一价和两价三价银离子的抗磁半导体晶体的电子活性。 当晶体被氧化剂活化时,它们释放相当于每分子6.4×10-19瓦特的电子,其实际上电致病菌。 许多这些装置在如化合物到制药的各种制剂中用作防腐剂的0.3PPM这样低的浓度下是有效的。 实际上,它们旨在作为用于破坏金黄色葡萄球菌等病原体的药物的活性成分,表皮葡萄球菌(表皮葡萄球菌)在0.6PPM的约100万个生物体的营养液培养物中完全破坏,或者是白色念珠菌,阴道酵母 感染2.5 PPM,艾滋病病毒18 PPM。
    • 9. 发明授权
    • Divalent silver halide bactericide
    • 二价卤化银杀菌剂
    • US5078902A
    • 1992-01-07
    • US697783
    • 1991-05-09
    • Marvin S. Antelman
    • Marvin S. Antelman
    • C02F1/50
    • C02F1/505C02F2103/42
    • Divalent silver halides provide a source for divalent bactericidal silver ions in the presence of persulfate. The halides are especially effective when applied to water used in industrial cooling installations, hot tubs and swimming pools and will conform to stringent EPA requirements for waters utilized for bathing as in tubs and pools of 100% kills of 100 K/cc E. Coli coliforms within 10 minutes, exemplary of which are the chloride and bromide which give 100% kills within 5 minutes. The halides, of course, can be used in salty water since they are solids immune from halide action that would otherwise precipitate soluble divalent silver from solution.
    • 二价卤化银在过硫酸盐存在下提供二价杀菌银离子的来源。 当适用于工业冷却装置,热水浴缸​​和游泳池中使用的水时,卤化物特别有效,并符合EPA所规定的用于沐浴的水,如100%杀死100K / cc大肠杆菌的桶和池。大肠杆菌 在10分钟内,其示例是在5分钟内产生100%杀死的氯化物和溴化物。 当然,卤化物可以在咸水中使用,因为它们是固体免于卤化物作用,否则会从溶液中沉淀出可溶性二价银。
    • 10. 发明授权
    • Methods of using electron active compounds for managing cancer
    • 使用电子活性化合物治疗癌症的方法
    • US06485755B1
    • 2002-11-26
    • US09692488
    • 2000-10-20
    • Marvin S. Antelman
    • Marvin S. Antelman
    • A61K3338
    • A61K8/0208A61K8/19A61K9/0014A61K9/0019A61K9/06A61K33/24A61K33/245A61K33/26A61K33/32A61K33/34A61K33/38A61K45/06A61K47/06A61Q1/12A61Q19/00C01G3/02
    • The present invention provides methods for preventing, treating, and/or managing one or more cancerous conditions in a patient, such as a human. A multivalent metal oxide, such as Ag(I,III), Cu(I,III), Pr(III,IV), and Bi(III,V) oxides or a pharmaceutically acceptable derivative thereof, may be administered to the patient in an amount and for a period of time which is therapeutically effective to prevent, treat, and/or manage such condition(s). These cancerous conditions include systemic and external cancers, and may also include conditions and symptoms associated with cancer. The present invention also provides a pharmaceutical composition suitable for treating such cancerous conditions. The compositions of the invention may be adapted for at least one of subcutaneous injection, intramuscular injection, intravenous injection, infusion, transdermal, or topical application.
    • 本发明提供了用于预防,治疗和/或控制患者(例如人)中的一种或多种癌症的方法。 可以向患者施用多价金属氧化物,例如Ag(I,III),Cu(I,III),Pr(III,IV)和Bi(III,V)氧化物或其药学上可接受的衍生物 治疗和/或管理这些病症的治疗有效量和一段时间。 这些癌症状况包括全身和外部癌症,并且还可包括与癌症相关的病症和症状。 本发明还提供了适用于治疗这种癌症的药物组合物。 本发明的组合物可以适用于皮下注射,肌内注射,静脉内注射,输注,透皮或局部应用中的至少一种。